UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
of the
SECURITIES EXCHANGE ACT OF 1934
Date of Event Requiring Report: May 7, 2002
NOVAMED, INC.
(Exact Name of Registrant as Specified on its Charter)
000-26927 77-0443643
--------- ----------
(Commission File Number) (IRS Employer Identification Number)
NEVADA
(State or Other Jurisdiction of Incorporation or Organization)
1403 East 900 South, Salt Lake City, Utah 84105
-----------------------------------------------
(Address of Principal Executive Offices)
(801) 582 9609
--------------
(Registrant's Telephone Number, Including Area Code)
ITEM 5. Other Events
On May 7, 2002, NovaMed Inc., ("Company") effected a fifty to one (50:1) reverse
split of its common stock. The Company currently has 869,858 common shares
issued and outstanding.
The decision to effect the reverse split was resolved to enable a capital
restructuring made necessary due to the winding down of the Company's breast
implant business. Management intends to seek a new business opportunity that
might create value for the Company's shareholders. The Company's new symbol on
the OTC.BB is "NOMD".
Pursuant to the requirement of the Securities Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: May 21, 2002
NovaMed, Inc.
A Nevada corporation
By: /s/ Ruairidh Campbell
------------------------
Ruairidh Campbell
President
1